Loading the map…
Research and experimental development on biotechnology · Didcot
Amber Therapeutics Holdings
Amber Therapeutics Holdings Limited
Private limited company registered in Didcot, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2025 · As filed (group accounts)
Turnover
For subscribers
Profit after tax
−£28.3m
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
4 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022* | 2023 | 2024* | 2025 |
|---|---|---|---|---|---|
| Profit after tax | −£28.3m | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed assets | ||||
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Return on equityProfit after tax as a share of net assets | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
7 balance-sheet lines and 4 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-11-01
- SharesStatement of capital following an allotment of shares on 15 October 2026 · GBP 15,947.226 (and 15 more like it since 4 May 2021)
- AccountsGroup of companies' accounts made up to 31 December 2025
- FilingMemorandum and Articles of Association (and 2 more like it since 12 July 2021)
- FilingResolutions (and 6 more like it since 30 April 2021)
- OwnershipNotification of Oxford Science Enterprises Holdings Ii Limited as a person with significant control on 28 May 2025
- OwnershipCessation of Oxford Science Enterprises Plc as a person with significant control on 28 May 2025
- DirectorsReplacement Filing for the appointment of Mr David Rogers Amerson as a director
- AccountsGroup of companies' accounts made up to 31 December 2024
- AddressRegistered office address changed from Cannon Place 78 Cannon Street London EC4N 6AF England to Unit 1 Tech Foundry 2 Curie Avenue Didcot OX11 0QQ on 17 June 2025
- SharesSecond filing of a statement of capital following an allotment of shares on 15 April 2025 · GBP 8,629.505 (and 3 more like it since 30 June 2021)
- DirectorsAppointment of Mr Dave Amerson as a director on 15 April 2025
- AccountsGroup of companies' accounts made up to 31 December 2023
24 earlier
- NameCertificate of change of name
- NameChange of name notice
- OwnershipNotification of Oxford Science Enterprises Plc as a person with significant control on 23 May 2024
- OwnershipWithdrawal of a person with significant control statement on 31 May 2024
- DirectorsTermination of appointment of Tim Denison as a director on 23 May 2024
- DirectorsTermination of appointment of Jonathan Martin Glenn as a director on 30 April 2024
- DirectorsAppointment of Tiffany Le as a director on 23 May 2024
- DirectorsAppointment of Caroline Butler as a director on 23 May 2024
- DirectorsAppointment of Yen-Min Kevin Chu as a director on 23 May 2024
- DirectorsDirector's details changed for Aidan Harold Winston Crawley on 1 October 2021
- DirectorsAppointment of Mr Jonathan Martin Glenn as a director on 1 December 2023
- SharesParticulars of variation of rights attached to shares
- SharesChange of share class name or designation
- AddressRegistered office address changed from 42 Sutherland Place London W2 5BY England to Cannon Place 78 Cannon Street London EC4N 6AF on 17 August 2023
- AccountsTotal exemption full accounts made up to 31 December 2022
- AccountsTotal exemption full accounts made up to 31 December 2021
- OwnershipNotification of a person with significant control statement
- OwnershipCessation of Aidan Harold Winston Crawley as a person with significant control on 18 June 2021
- DirectorsSecond filing for the appointment of Mr Tim Denison as a director
- AddressRegistered office address changed from 17 Stanley Gardens London W11 2NG England to 42 Sutherland Place London W2 5BY on 30 June 2021
- DirectorsAppointment of Tim Denison as a director on 9 May 2021
- DirectorsAppointment of Liliane Chamas as a director on 18 June 2021
- SharesSub-division of shares on 8 April 2021
- IncorporationIncorporation
- Name
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Amber Therapeutics Holdings do?
Private limited company registered in Didcot, classed under “Research and experimental development on biotechnology”.
›How much turnover does Amber Therapeutics Holdings make?
Answered in the full report
›Is Amber Therapeutics Holdings profitable?
No: it made a loss after tax of £28.3m in the year to 31 December 2025, its latest filed accounts.
›How many people work at Amber Therapeutics Holdings?
Answered in the full report
›Who runs and owns Amber Therapeutics Holdings?
Its directors are David Rogers Amerson, Caroline Butler, Liliane Doctor Chamas, Yen-Min Kevin Chu, Aidan Harold Winston Crawley and 1 more. Its owners are shown to subscribers.
›Where is Amber Therapeutics Holdings based?
Its registered office is Unit 1 Tech Foundry 2, Curie Avenue, Didcot, OX11 0QQ, in Didcot.
›When was Amber Therapeutics Holdings founded?
Amber Therapeutics Holdings Limited was incorporated on 18 December 2020.
›Is Amber Therapeutics Holdings still trading?
The register lists Amber Therapeutics Holdings Limited as active.